Literature DB >> 16275417

Tracheomalacia secondary to obstructive sleep apnea.

Christopher A Peters1, Murray D Altose, James M Coticchia.   

Abstract

Tracheomalacia (TM) is abnormal flaccidity of the trachea caused by inadequate cartilaginous support by the C-shaped tracheal rings. This defect generally results in various degrees of dynamic narrowing of the airway lumen. TM usually presents with expiratory stridor, wheeze, and respiratory obstruction. TM is usually associated with tracheoesophageal fistula and esophageal atresia or with other thoracic lesions of vascular rings and tumors. We report a well-documented case of a 20-month-old boy who presented to our institution with a severe history of obstructive sleep apnea and adenotonsillar hypertrophy. On direct laryngoscopy/bronchoscopy, severe TM was noted. Tonsillectomy and adenoidectomy was performed, and by the 37th postoperative day, the TM had completely resolved. We review the literature, discuss the differential diagnosis and clinical evaluation, and propose a new pathophysiological mechanism by which obstructive sleep apnea causes TM.

Entities:  

Mesh:

Year:  2005        PMID: 16275417     DOI: 10.1016/j.amjoto.2005.05.008

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  3 in total

1.  [Subglottic tracheal stenosis].

Authors:  N Karaiskaki; W J Mann
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

Review 2.  OSA and Chronic Respiratory Disease: Mechanisms and Epidemiology.

Authors:  Brian W Locke; Janet J Lee; Krishna M Sundar
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

3.  Semiquantitative Chest Computed Tomography Assessment Identifies Expiratory Central Airway Collapse in Symptomatic Military Personnel Deployed to Iraq and Afghanistan.

Authors:  Silpa D Krefft; Andrea Oh; Lauren M Zell-Baran; Jenna Wolff; Camille M Moore; Tony V Macedonia; Cecile S Rose
Journal:  J Thorac Imaging       Date:  2022-03-01       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.